Scaldaferri, F., Pugliese, D., Privitera, G., Onali, S., Lopetuso, L. R., Rizzatti, G., Settanni, C. R., Pizzoferrato, M., Schiavoni, E., Turchini, L., Amatucci, V., Napolitano, D., Bernabei, T., Mora, V., Laterza, L., Papa, A., Guidi, L., Rapaccini, G. L., Gasbarrini, A., & Armuzzi, A. (2020). impact of COVID‐19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high‐volume Italian inflammatory bowel disease centre. United European Gastroenterology journal, 8(7), 775–781. http://access.bl.uk/ark:/81055/vdc_100124385587.0x000006